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Abstract
Topical antiseptics are commonly used in the management of minor wounds, burns, and infected skin. These
agents are widely used by health professionals and are often self-prescribed by patients as they are easily available
over-the-counter. This case illustrates a 73 year old man who presented with a non-healing wound on his right
forearm for 4 weeks. The wound started from an insect bite and progressively enlarged with increasing pruritus
and burning sensation. Clinically an ill-defined ulcer with surrounding erythema and erosion was noted. There was
a yellow crust overlying the center of the ulcer and the periphery was scaly. Further inquiry revealed history of self
treatment with a yellow solution to clean his wound for 3 weeks. Patient was provisionally diagnosed to have
allergic contact dermatitis secondary to acriflavine. Topical acriflavine was stopped and the ulcer resolved after
treatment with non-occlusive saline dressing. Skin patch test which is the gold standard for detection and
confirmation of contact dermatitis showed a positive reaction (2+) to acriflavine. Acriflavine is widely used as a
topical antiseptic agent in this part of the world. Hence, primary care physicians managing a large variety of poorly
healing wounds should consider the possibility of contact allergy in recalcitrant cases, not responding to
conventional treatment. Patient education is an important aspect of management as this would help curb the
incidence of future contact allergies.
Background
Acriflavine lotion is a topical antiseptic solution yellow
or orange in colour, mainly used for minor wounds,
burns, and infected skin. Although used in dilution
(0.1%) for medical purposes, this agent has been docu-
mented to produce potential skin itchiness, irritation or
burning sensation upon contact. Nevertheless, it is still
widely used for wound dressing by health professionals
and remains a popular topical antiseptic agent pur-
chased over-the-counter.
Case presentation
We report a case of a 73 year old man presenting with a
non healing wound on his right forearm for 4 weeks.
The wound started from an insect bite and progressively
enlarged with increasing pruritus and burning sensation.
Clinically an ill-defined ulcer was seen on his right fore-
arm with surrounding erythema and erosion. There was
a yellow crust overlying the center of the ulcer and the
periphery was scaly (Figure 1). Further inquiry revealed
history of self treatment with a yellow solution to clean
his wound for 3 weeks. He could not recall using the
solution in the past and did not seek any medical advice
prior to the current visit. Patient was provisionally diag-
nosed to have allergic contact dermatitis secondary to
acriflavine. Acriflavine usage was stopped and the ulcer
was treated with daily non-occlusive saline dressing. The
lesion improved a week later looking noticeably dry, less
inflamed and smaller in diameter (Figure 2). At the end
of two weeks, there was complete resolution of the
ulcer, leaving a residual post-inflammatory hyperpig-
mentation. A patch test using Standard European series
(Chemotechnique) containing 28 different allergens and
acriflavine was done seven months later. The result
showed a positive reaction (2+) to acriflavine while the
rest were negative.
A c r i f l a v i n eo rc o m m o n l yk n o w na sF l a v i n ,i sa na c r i -
dine derivative of proflavin used as a topical antiseptic
agent. It is a yellow or orange colour solution which
stains the skin and may cause irritation, inflammation
or blister upon contact [1]. It is commonly used as skin
disinfectant for minor wounds, burns, infected skin and
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teria [1]. Acriflavine was initially used during the First
World War as a treatment for African trypanosomiasis
(sleeping sickness). In addition to its disinfecting prop-
erty, it has also been shown to inhibit cancer progres-
sion in animals [2]. Although used in dilution (0.1%), it
has been documented to produce potential skin irrita-
tion and is still widely used for wound dressing in both
hospitals and outpatient clinics.
Contact dermatitis is an eczematous symptom occur-
ring as a result of skin exposure to an irritant or sensi-
tizing agent. It is generally categorized as allergic
contact dermatitis and irritant contact dermatitis. Aller-
gic contact dermatitis is an immune mediated inflamma-
tory reaction while irritant contact dermatitis is a non-
allergic inflammatory reaction causing direct cell
damage resulting in skin dryness, redness or even burns
[3]. Common antibacterials and antiseptics that cause an
allergic reaction are Neomycin (40.6%), Soframycin
(15.1%), Dettol (10.9%), Savlon (8.3%) and Acriflavine
(5.2%) [4,5]. Besides contact dermatitis, acriflavine has
also been shown to cause perioral and mucosal odema
[6].
Individuals of all age groups and ethnicity have poten-
tial risk for developing contact dermatitis ranging from
diaper dermatitis in infants to hair dye and fragrance
dermatitis in the elderly [1]. Various studies have shown
increasing prevalence of contact dermatitis to topical
medicaments with advancing age [7,8]. This is probably
due to the fact the elderly have been exposed to multi-
ple allergens during their life time compared to younger
individuals. Atopic individuals were previously thought
to be more susceptible to contact dermatitis. However, a
definite relationship between atopic dermatitis and con-
tact dermatitis is yet to be established as current evi-
dence show controversial results [1].
Typical features of dermatitits medicamentosa are non
healing wound, worsening or enlarging wound with pre-
sence of surrounding dermatitis. Staining of the wound
provides a clue to identify the irritant; yellow (acrifla-
vine) or dark brown (potassium permanganate). The
reaction is usually gradual and not an acute event.
H e n c ep a t i e n t sa r eu s u a l l yu n a w a r eo ft h eu n d e r l y i n g
cause for the reaction which further delays wound heal-
ing. Withholding the irritant and appropriate topical
management speeds up recovery.
Patch test is the gold standard for detection and confir-
mation of contact dermatitis. This is a simple yet cost
effective test that facilitates early and accurate detection of
underlying cause for suspected contact dermatitis [9]. It
also serves as an important tool in patient education to
avoid further exposure to the known allergens. Although
the test is simple to perform, adequate experience and
training is required for accurate interpretation of the
results. Patch test is best avoided during an acute reaction
and performed about six months after an initial contact to
prevent further aggravation of the existing dermatitis [1].
Conclusion
Acriflavine remains as a widely used topical antiseptic
agent in this part of the world. Hence, primary care
physicians managing a large variety of poorly healing
wounds should consider the possibility of contact allergy
in recalcitrant cases, not responding to conventional
treatment. A detailed history of the wound, from the
initial onset till presentation and the different types of
treatments, either from their own kitchen (home reme-
dies), over-the-counter purchase and type of dressing
solutions used should be inquired. History of previous
local reactions to antiseptic solutions and possible cross
reactions should also be clearly documented. Patient
Figure 1 Right forearm showing ulcer with central yellow crust
surrounded by erythema and erosion.
Figure 2 The ulcer is dry, less inflamed and smaller a week
after withholding acriflavin.
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would help curb incidence of future contact allergies.
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